Histone deacetylase inhibitor impairs plasminogen activator inhibitor-1 expression via inhibiting TNF-α-activated MAPK/AP-1 signaling cascade

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Wei Lin ^a   Sheu, Joen Rong ^a   Hsiao, Che Jen ^a   Hsiao, Shih Hsin ^b   Chung, Chi Li ^a,b   Hsiao, George ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CARBOXYCINNAMIC ACID BISHYDROXAMIDE; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ATF2 PROTEIN, HUMAN; DUSP1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SERPINE1 PROTEIN, HUMAN;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRIN DEPOSITION; FIBROGENESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESOTHELIUM CELL; PLEURAL FIBROSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL CULTURE; DRUG EFFECTS; EPITHELIUM; GENETICS; PROMOTER REGION;

ACTIVATING TRANSCRIPTION FACTOR 2; CELLS, CULTURED; DUAL SPECIFICITY PHOSPHATASE 1; EPITHELIUM; HISTONE DEACETYLASE INHIBITORS; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897879212     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/231012     Document Type: Article

References (26)

1. Jantz M. A., Antony V. B., Pleural fibrosis. Clinics in Chest Medicine 2006 27 2 181 191 2-s2.0-33646577187 10.1016/j.ccm.2005.12.003 (Pubitemid 43729187)
2. Idell S., Zwieb C., Kumar A., Koenig K. B., Johnson A. R., Pathways of fibrin turnover of human pleural mesothelial cells in vitro. The American Journal of Respiratory Cell and Molecular Biology 1992 7 4 414 426 2-s2.0-0026931244
3. Chung C.-L., Chen C.-H., Sheu J.-R., Chen Y.-C., Chang S.-C., Proinflammatory cytokines, transforming growth factor- β 1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest 2005 128 2 690 697 2-s2.0-23744505469 10.1378/chest.128.2.690 (Pubitemid 41140497)
4. Orphanidou D., Gaga M., Rasidakis A., Dimakou K., Toumbis M., Latsi P., Pandalos J., Christacopoulou J., Jordanoglou J., Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion. Respiratory Medicine 1996 90 2 95 98 2-s2.0-0029936496 10.1016/S0954-6111(96) 90205-X (Pubitemid 26109104)
5. Whawell S. A., Scott-Coombes D. M., Vipond M. N., Tebbutt S. J., Thompson J. N., Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells. British Journal of Surgery 1994 81 2 214 216 2-s2.0-0028343962 (Pubitemid 24122353)
6. Hua C.-C., Chang L.-C., Chen Y.-C., Chang S.-C., Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 1999 116 5 1292 1296 2-s2.0-0032724687 10.1378/chest.116.5.1292 (Pubitemid 29535983)
7. Lin F.-C., Chen Y.-C., Chen F.-J., Chang S.-C., Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. Clinical Immunology 2005 116 2 166 173 2-s2.0-21344439142 10.1016/j.clim.2005.03.015 (Pubitemid 40910243)
8. Yang X.-J., Seto E., HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007 26 37 5310 5318 2-s2.0-34547924046 10.1038/sj.onc.1210599 (Pubitemid 47255917)
9. Spange S., Wagner T., Heinzel T., Krämer O. H., Acetylation of non-histone proteins modulates cellular signalling at multiple levels. International Journal of Biochemistry and Cell Biology 2009 41 1 185 198 2-s2.0-56049090769 10.1016/j.biocel.2008.08.027
10. Ropero S., Esteller M., The role of histone deacetylases (HDACs) in human cancer. Molecular Oncology 2007 1 1 19 25 2-s2.0-34248631385 10.1016/j.molonc.2007.01.001 (Pubitemid 46776612)
11. Barnes P. J., Adcock I. M., Ito K., Histone acetylation and deacetylation: Importance in inflammatory lung diseases. European Respiratory Journal 2005 25 3 552 563 2-s2.0-14744285888 10.1183/09031936.05.00117504 (Pubitemid 40331188)
12. Ghosh A. K., Mori Y., Dowling E., Varga J., Trichostatin A blocks TGF- β -induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochemical and Biophysical Research Communications 2007 354 2 420 426 2-s2.0-33846548599 10.1016/j.bbrc.2006.12.204 (Pubitemid 46161342)
13. Duan H., Heckman C. A., Boxer L. M., Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Molecular and Cellular Biology 2005 25 5 1608 1619 2-s2.0-14044276343 10.1128/MCB.25.5.1608-1619.2005 (Pubitemid 40280131)
14. Kao Y. H., Liou J. P., Chung C. C., Lien G. S., Kuo C. C., Chen S. A., Chen Y. J., Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. International Journal of Cardiology 2013 168 4 4178 4183
15. Chung C.-L., Sheu J.-R., Chen W.-L., Chou Y.-C., Hsiao C.-J., Hsiao S.-H., Hsu M.-J., Cheng Y.-W., Hsiao G., Histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells. The American Journal of Respiratory Cell and Molecular Biology 2012 46 4 437 445 2-s2.0-84859390804 10.1165/rcmb.2011-0118OC
16. Guo W., Shan B., Klingsberg R. C., Qin X., Lasky J. A., Abrogation of TGF- β 1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. The American Journal of Physiology 2009 297 5 L864 L870 2-s2.0-72449139586 10.1152/ajplung.00128.2009
17. Chung C.-L., Sheu J.-R., Liu H.-E., Chang S.-C., Chou Y.-C., Chen W.-L., Chou D.-S., Hsiao G., Dynasore, a dynamin inhibitor, induces PAI-1 expression in MeT-5A human pleural mesothelial cells. The American Journal of Respiratory Cell and Molecular Biology 2009 40 6 692 700 2-s2.0-66349085317 10.1165/rcmb.2008-0087OC
18. Nasreen N., Mohammed K. A., Mubarak K. K., Baz M. A., Akindipe O. A., Fernandez-Bussy S., Antony V. B., Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF- β 1 in vitro. The American Journal of Physiology 2009 297 1 L115 L124 2-s2.0-67650088202 10.1152/ajplung.90587.2008
19. Vayalil P. K., Iles K. E., Choi J., Yi A.-K., Postlethwait E. M., Liu R.-M., Glutathione suppresses TGF- β -induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. The American Journal of Physiology 2007 293 5 L1281 L1292 2-s2.0-36349007768 10.1152/ajplung.00128.2007 (Pubitemid 350159412)
20. Dokmanovic M., Clarke C., Marks P. A., Histone deacetylase inhibitors: overview and perspectives. Molecular Cancer Research 2007 5 10 981 989 2-s2.0-36048958965 10.1158/1541-7786.MCR-07-0324 (Pubitemid 350080267)
21. Halili M. A., Andrews M. R., Labzin L. I., Schroder K., Matthias G., Cao C., Lovelace E., Reid R. C., Le G. T., Hume D. A., Irvine K. M., Matthias P., Fairlie D. P., Sweet M. J., Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. Journal of Leukocyte Biology 2010 87 6 1103 1114 2-s2.0-77954013043 10.1189/jlb.0509363
22. Baud V., Karin M., Signal transduction by tumor necrosis factor and its relatives. Trends in Cell Biology 2001 11 9 372 377 2-s2.0-0035444539 10.1016/S0962-8924(01)02064-5 (Pubitemid 32900529)
23. Kinugasa F., Noto T., Matsuoka H., Urano Y., Sudo Y., Takakura S., Mutoh S., Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction. Transplant Immunology 2010 23 1-2 18 23 2-s2.0-77953806859 10.1016/j.trim.2010.02.003
24. Theodosiou A., Smith A., Gillieron C., Arkinstall S., Ashworth A., MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases. Oncogene 1999 18 50 6981 6988 2-s2.0-0033604459 (Pubitemid 30028867)
25. Karin M., Hunter T., Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Current Biology 1995 5 7 747 757 2-s2.0-0029328342
26. Backs J., Worst B. C., Lehmann L. H., Patrick D. M., Jebessa Z., Kreusser M. M., Sun Q., Chen L., Heft C., Katus H. A., Olson E. N., Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. The Journal of cell biology 2011 195 3 403 415 2-s2.0-84855753309